These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33342152)

  • 1. [Current status and research progress of third-line treatment for patients with gastric cancer in China].
    Qi CS; Cheng SY; Shen L
    Zhonghua Zhong Liu Za Zhi; 2020 Dec; 42(12):983-988. PubMed ID: 33342152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy for Gastric Cancer: A Focus on Immune Checkpoints.
    Alsina M; Moehler M; Hierro C; Guardeño R; Tabernero J
    Target Oncol; 2016 Aug; 11(4):469-77. PubMed ID: 26880697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visual analysis of global research on immunotherapy for gastric cancer: A literature mining from 2012 to 2022.
    Chen Y; Chen Y; Tan S; Zheng Y; Liu S; Zheng T; Mi Y; Lin S; Yang C; Li W
    Hum Vaccin Immunother; 2023 Dec; 19(1):2186684. PubMed ID: 37017186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic Chemotherapy.
    Fanotto V; Uccello M; Pecora I; Rimassa L; Leone F; Rosati G; Santini D; Giampieri R; Di Donato S; Tomasello G; Silvestris N; Pietrantonio F; Battaglin F; Avallone A; Scartozzi M; Lutrino ES; Melisi D; Antonuzzo L; Pellegrino A; Ferrari L; Bordonaro R; Vivaldi C; Gerratana L; Bozzarelli S; Filippi R; Bilancia D; Russano M; Aprile G
    Oncologist; 2017 Dec; 22(12):1463-1469. PubMed ID: 28860412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Research Progress of Immunotherapy for Gastric Cancer.
    Zhang Z; Liu N; Sun M
    Technol Cancer Res Treat; 2023; 22():15330338221150555. PubMed ID: 37042029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late-line treatment in metastatic gastric cancer: today and tomorrow.
    Smyth EC; Moehler M
    Ther Adv Med Oncol; 2019; 11():1758835919867522. PubMed ID: 31489035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical management of gastric cancer: a 2017 update.
    Charalampakis N; Economopoulou P; Kotsantis I; Tolia M; Schizas D; Liakakos T; Elimova E; Ajani JA; Psyrri A
    Cancer Med; 2018 Jan; 7(1):123-133. PubMed ID: 29239137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival in Advanced Esophagogastric Adenocarcinoma Improves With Use of Multiple Lines of Therapy: Results From an Analysis of More Than 500 Patients.
    Davidson M; Cafferkey C; Goode EF; Kouvelakis K; Hughes D; Reguera P; Kalaitzaki E; Peckitt C; Rao S; Watkins D; Chau I; Cunningham D; Starling N
    Clin Colorectal Cancer; 2018 Sep; 17(3):223-230. PubMed ID: 29980492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation and treatment of malignant ascites secondary to gastric cancer.
    Maeda H; Kobayashi M; Sakamoto J
    World J Gastroenterol; 2015 Oct; 21(39):10936-47. PubMed ID: 26494952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apatinib in gastric carcinoma: A case report of partial response for first-line treatment in advanced disease.
    Wang Y; Bi M; Zhang H; Gao Z; Zhou H; Chang S
    Asia Pac J Clin Oncol; 2017 Oct; 13(5):e528-e530. PubMed ID: 28028915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of checkpoint inhibitors for the treatment of metastatic gastric cancers: Current status and future perspectives.
    Taieb J; Moehler M; Boku N; Ajani JA; Yañez Ruiz E; Ryu MH; Guenther S; Chand V; Bang YJ
    Cancer Treat Rev; 2018 May; 66():104-113. PubMed ID: 29730461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Third line treatment of advanced oesophagogastric cancer: A critical review of current evidence and evolving trends.
    Edwards P; Davidson M; Calamai V; Cunningham D; Starling N
    Cancer Treat Rev; 2018 Dec; 71():32-38. PubMed ID: 30343173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current status and prospects of clinical research on diagnosis and treatment of gastric cancer in China].
    Xu HM; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Feb; 23(2):109-114. PubMed ID: 32074788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current questions for the treatment of advanced gastric cancer.
    Cervantes A; Roda D; Tarazona N; Roselló S; Pérez-Fidalgo JA
    Cancer Treat Rev; 2013 Feb; 39(1):60-7. PubMed ID: 23102520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy for advanced gastric cancer.
    Wagner AD; Unverzagt S; Grothe W; Kleber G; Grothey A; Haerting J; Fleig WE
    Cochrane Database Syst Rev; 2010 Mar; (3):CD004064. PubMed ID: 20238327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current status and research progress of perioperative chemotherapy in advanced gastric cancer].
    Liu N; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Oct; 18(10):983-5. PubMed ID: 26499140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted therapies in metastatic gastric cancer: Current knowledge and future perspectives.
    Pellino A; Riello E; Nappo F; Brignola S; Murgioni S; Djaballah SA; Lonardi S; Zagonel V; Rugge M; Loupakis F; Fassan M
    World J Gastroenterol; 2019 Oct; 25(38):5773-5788. PubMed ID: 31636471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of Taxanes on Treatment Sequence in Gastric Cancer.
    Lorenzen S; Stahl M; Hofheinz RD; Al-Batran SE; Lordick F
    Oncol Res Treat; 2020; 43(1-2):42-47. PubMed ID: 31634892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on gastric cancer treatments and gene therapies.
    Biagioni A; Skalamera I; Peri S; Schiavone N; Cianchi F; Giommoni E; Magnelli L; Papucci L
    Cancer Metastasis Rev; 2019 Sep; 38(3):537-548. PubMed ID: 31486976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current status of neoadjuvant immunotherapy for the treatment of gastric cancer.
    Zhang X; Liu B; Wang R; Li X; Zhou W
    Clin Transl Oncol; 2024 Mar; ():. PubMed ID: 38504071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.